[go: up one dir, main page]

MX2012000943A - Metodos para atenuar la perdida de estatus funcional. - Google Patents

Metodos para atenuar la perdida de estatus funcional.

Info

Publication number
MX2012000943A
MX2012000943A MX2012000943A MX2012000943A MX2012000943A MX 2012000943 A MX2012000943 A MX 2012000943A MX 2012000943 A MX2012000943 A MX 2012000943A MX 2012000943 A MX2012000943 A MX 2012000943A MX 2012000943 A MX2012000943 A MX 2012000943A
Authority
MX
Mexico
Prior art keywords
loss
functional status
methods
attenuating
attenuate
Prior art date
Application number
MX2012000943A
Other languages
English (en)
Inventor
Kevin Burke Miller
Zamzam Kabiry Roughead
Ingo Arne Jurk
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2012000943A publication Critical patent/MX2012000943A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/08—Mydriatics or cycloplegics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)

Abstract

Se proporcionan composiciones nutricionales y métodos de uso de las composiciones nutricionales con ejercicio para atenuar la pérdida de estatus funcional. En una modalidad general, la presente descripción proporciona una composición nutricional que incluye proteína de suero lácteo, y vitamina D. La composición nutricional y el ejercicio pueden ser usados de manera específica para atenuar la pérdida de estatus funcional, en especial en las personas ancianas.
MX2012000943A 2009-07-20 2010-07-15 Metodos para atenuar la perdida de estatus funcional. MX2012000943A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22680609P 2009-07-20 2009-07-20
US33424710P 2010-05-13 2010-05-13
PCT/US2010/042083 WO2011011252A1 (en) 2009-07-20 2010-07-15 Methods of attenuating the loss of functional status

Publications (1)

Publication Number Publication Date
MX2012000943A true MX2012000943A (es) 2012-02-28

Family

ID=42990259

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012000943A MX2012000943A (es) 2009-07-20 2010-07-15 Metodos para atenuar la perdida de estatus funcional.

Country Status (13)

Country Link
US (1) US20120195873A1 (es)
EP (2) EP3231435A1 (es)
JP (1) JP2012533627A (es)
CN (1) CN102647990A (es)
AU (1) AU2010274125B2 (es)
BR (1) BR112012001488A2 (es)
CA (1) CA2768471A1 (es)
IN (1) IN2012DN00486A (es)
MX (1) MX2012000943A (es)
RU (1) RU2012105901A (es)
SG (1) SG177664A1 (es)
WO (1) WO2011011252A1 (es)
ZA (1) ZA201201229B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2681849T3 (es) * 2010-03-12 2018-09-17 Nestec S.A. Composiciones para enmascarar el sabor de la leucina y métodos para producirlas
CN103025178B (zh) * 2010-04-26 2015-02-11 雀巢产品技术援助有限公司 用于从胃肠外营养转换至肠内营养的营养组合物和方法
WO2012005568A1 (en) 2010-07-07 2012-01-12 N.V. Nutricia Nutritional composition for the stimulation of muscle protein synthesis
AU2012220068A1 (en) * 2011-02-25 2013-10-10 Merck Patent Gmbh Composition to increase joint and/or postural stability
MX2013012230A (es) * 2011-04-18 2014-06-05 Nestec Sa Composiciones nutricionales que tienen a-hica y citrulina y metodos para utilizar las mismas.
EP2717705A1 (en) * 2011-06-08 2014-04-16 Nestec S.A. Nutritional compositions having exogenous milk fat globule membrane components
JP2013051920A (ja) * 2011-09-05 2013-03-21 Ishikawa Prefectural Public Univ Corp 骨密度強化補助食品
EP2580967A1 (en) 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
EP2583565A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for enhancing energy expenditure and satiety
EP2583563A1 (en) 2011-10-21 2013-04-24 Nestec S.A. Whey protein micelles against muscle atrophy and sarcopenia
ES2550321T3 (es) * 2011-10-21 2015-11-06 Nestec S.A. Micelas de proteína de suero para aumentar la masa muscular y el rendimiento
SG11201402906PA (en) * 2012-01-03 2014-10-30 Nestec Sa Compositions and methods for the stability of reactive amino acids in a food matrix
RU2520036C2 (ru) * 2012-03-01 2014-06-20 Общество с ограниченной ответственностью "Институт новых технологий" Пищевой продукт "миоактив-спорт" для питания людей, подверженных интенсивным физическим нагрузкам
CN104837369B (zh) 2012-10-04 2017-03-08 雅培制药有限公司 用于增强EGCg对减缓骨骼肌损失的作用的方法
CN103783532B (zh) * 2012-10-29 2016-06-08 杭州纽曲星生物科技有限公司 一种抗老年性肌肉衰减的复合蛋白质粉及其制备方法
CN103271350B (zh) * 2013-03-04 2014-09-24 中国航天员科研训练中心 空间站航天员太空高能压缩食品及其制法
JP2016513701A (ja) * 2013-03-14 2016-05-16 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 長期身体不活動に関連するインスリン抵抗性の治療
BR112015023031A2 (pt) 2013-03-15 2017-07-18 Abbott Lab métodos de conservação e melhoria da função múscular
JP6753775B2 (ja) * 2013-04-15 2020-09-09 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 電気筋肉刺激と組み合わせられるホエータンパク質の使用
CN105188413A (zh) * 2013-05-01 2015-12-23 雅培公司 增强老化肌肉再生的方法
WO2014191856A1 (en) * 2013-05-31 2014-12-04 Nestec S.A. Methods for enhancement of muscle protein synthesis
PL3021690T3 (pl) 2013-06-10 2017-10-31 Nutricia Nv Ochrona mięśni w trakcie programu spadku wagi u osób z nadwagą lub otyłych dorosłych
JP6279851B2 (ja) * 2013-07-19 2018-02-14 雪印メグミルク株式会社 筋萎縮防止及び／又は筋合成促進剤
WO2016012403A1 (en) 2014-07-21 2016-01-28 Nestec S.A. Nutritional products to promote safe swallowing for individuals with dysphagia
PL3006027T3 (pl) * 2014-10-08 2018-02-28 Professional Dietetics S.P.A. Kompozycje zawierające aminokwasy do stosowania w leczeniu ogólnoustrojowego stanu zapalnego związanego z udarem u pacjentów z dysfagią
AU2015332935B2 (en) * 2014-10-14 2020-11-26 Société des Produits Nestlé S.A. Improvement in muscle functionality of elderly males
WO2016078954A1 (en) * 2014-11-19 2016-05-26 Nestec S.A. Use of complexes of whey protein micelles and pectin for managing body weight
BR112018008186B1 (pt) * 2015-11-20 2021-11-23 Société des Produits Nestlé S.A. Composição que compreende micelas de proteína de soro de leite, e seus usos
SG11201804602SA (en) * 2015-12-03 2018-06-28 Meiji Co Ltd Nutritional composition
JP6935403B2 (ja) * 2015-12-22 2021-09-15 ソシエテ・デ・プロデュイ・ネスレ・エス・アー サルコペニア及びフレイルの処置方法
TW201808120A (zh) * 2016-03-16 2018-03-16 味之素股份有限公司 行動體力提升劑
CN109195596A (zh) * 2016-04-14 2019-01-11 迈克尔·露西 组合物及其使用方法
JP6948103B2 (ja) * 2016-04-14 2021-10-13 株式会社明治 フレイル改善用組み合わせ物
AU2017270131B2 (en) * 2016-05-27 2023-03-09 Société des Produits Nestlé S.A. Nutritional composition for treating or preventing impaired mobility
HRP20201141T1 (hr) * 2016-11-16 2020-10-30 Fresenius Kabi Deutschland Gmbh Nutritivna kompozicija za primjenu u terapiji pacijenata sa sarkopenijom i/ili slabošću ili pacijenta sa presarkopenijom i/ili pred-slabošću
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
US11504413B2 (en) 2017-03-03 2022-11-22 Exerkine Corporation Multi-nutrient composition
JP7198749B2 (ja) * 2017-06-01 2023-01-04 株式会社明治 栄養組成物
US10682325B2 (en) 2017-08-14 2020-06-16 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
JP7044306B2 (ja) * 2018-07-31 2022-03-30 ユーハ味覚糖株式会社 ロイシン血中濃度上昇促進剤及びその用途
CA3122323A1 (en) * 2018-12-13 2020-06-18 Societe Des Produits Nestle S.A. Liquid concentrates formulated for dilution into nutritional products to promote safe swallowing for individuals with dysphagia
IL288801B2 (en) * 2019-06-28 2025-02-01 Dompe Farm Spa Preparations containing non-branched chain acids
WO2021079987A1 (ja) * 2019-10-25 2021-04-29 味の素株式会社 筋質向上剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2683492B2 (ja) * 1993-09-07 1997-11-26 雪印乳業株式会社 ミセル状ホエー蛋白質、その溶液、その粉末およびミセル状ホエー蛋白質の製造法
CN1101810A (zh) * 1994-08-23 1995-04-26 谢宝兴 茯苓枸杞子口服液饮料袋泡茶及其生产方法
EP1062876A1 (en) * 1999-02-25 2000-12-27 Societe Des Produits Nestle S.A. Caseinoglycomacropeptides as calcification agent
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
US7794770B2 (en) * 2004-10-07 2010-09-14 Next Proteins, Inc. Protein beverage and method of making the same
CA2537647A1 (en) * 2005-03-01 2006-09-01 Six Star Formulations Ltd. Supplemental dietary composition for supporting muscle growth, recovery and strength
FR2882896B1 (fr) * 2005-03-14 2007-05-04 Larena Sa Composition alimentaire pour prevenir le syndrome de fragilite chez les personnes agees
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate
US20070036873A1 (en) 2005-07-27 2007-02-15 Shibnath Ghosal Method of treatment or management of stress
CA2621739A1 (en) * 2005-09-09 2007-03-15 Murray Goulburn Co-Operative Co. Limited Composition of whey growth factor extract for reducing muscle inflammation
DE602006019941D1 (de) * 2006-03-27 2011-03-17 Nestec Sa Im Proteingehalt angereichertes gefrorenes Dessert
ES2322181T3 (es) * 2006-03-27 2009-06-17 Nestec S.A. Preparacion in situ de micelas de proteinas de suero de leche.
CA2666871C (en) * 2006-10-19 2011-08-30 Nestec S.A. Long term feed - cancer patient
AR060847A1 (es) 2007-05-03 2008-07-16 Spannagel Lucia Antonia Formulacion a base de calendula, aloe y centella.
EP2288268A1 (en) * 2008-05-21 2011-03-02 Stokely-Van Camp, Inc. Milk-based recovery beverage
WO2010002242A1 (en) * 2008-07-02 2010-01-07 N.V. Nutricia Nutritional composition for improving muscle function and daily activity

Also Published As

Publication number Publication date
IN2012DN00486A (es) 2015-05-22
RU2012105901A (ru) 2013-08-27
US20120195873A1 (en) 2012-08-02
WO2011011252A1 (en) 2011-01-27
AU2010274125B2 (en) 2015-11-05
AU2010274125A1 (en) 2012-02-16
ZA201201229B (en) 2013-07-31
SG177664A1 (en) 2012-02-28
EP2456448A1 (en) 2012-05-30
JP2012533627A (ja) 2012-12-27
EP3231435A1 (en) 2017-10-18
CA2768471A1 (en) 2011-01-27
CN102647990A (zh) 2012-08-22
BR112012001488A2 (pt) 2019-10-08

Similar Documents

Publication Publication Date Title
MX2012000943A (es) Metodos para atenuar la perdida de estatus funcional.
PH12012500740A1 (en) Nutritional compositions including a high protein component and exogenous nucleotides
WO2013122932A3 (en) Topical use of a skin-commensal prebiotic agent and compositions containing the same
ZA201103584B (en) Whey protein compositions,methods and uses
IN2012DN01920A (es)
GEP201706733B (en) Anti-il-23 antibodies
IN2015DN03322A (es)
ZA201300690B (en) Hypocaloric,high protein nutritional compositions and methods of using same
IN2014CN02970A (es)
HK1199378A1 (en) Compositions and methods for use in promoting lean body mass
WO2010141606A3 (en) Human gonadal stem cells
MX2013012136A (es) Composiciones que comprenden un antimetabolito de glucosa y selenio.
WO2011019641A3 (en) Nutritional compositions including exogenous nucleotides
PH12013500917A1 (en) Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
MX2010008280A (es) Composicion para estimular la actividad de celula asesina natural.
MX342306B (es) Composicion de chocolate aireada.
WO2012006585A3 (en) Use of interleukin-15 to treat cardiovascular diseases
WO2011037712A3 (en) Nutritional compositions including theanine and exogenous nucleotides
WO2012036414A3 (ko) 발효콩 추출 분획물을 유효 성분으로 포함하는 화장료 조성물
PL2535047T3 (pl) Kompozycja odżywcza, suplement diety zawierający kompozycję odżywczą i zestaw zawierający suplement diety
WO2012081893A3 (ko) 신규한 3-인돌리논 유도체 및 이를 포함하는 조성물
WO2012119049A3 (en) Nutritional compositions comprising prune extract and bioavailable curcumin
GEP20156373B (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
WO2013100585A3 (ko) 세복수초 추출물 또는 그 유효물질을 이용한 항암제 조성물
WO2013079924A3 (en) Modified exonuclease

Legal Events

Date Code Title Description
FA Abandonment or withdrawal